Table: begin end state 1 36 signal peptide 37 63 non-cytoplasmic 64 85 transmembrane 86 96 cytoplasmic 97 119 transmembrane 120 124 non-cytoplasmic 125 144 transmembrane 145 149 cytoplasmic 150 175 transmembrane 176 180 non-cytoplasmic 181 201 transmembrane 202 204 cytoplasmic 205 224 transmembrane 225 242 non-cytoplasmic 243 272 transmembrane 273 283 cytoplasmic 284 302 transmembrane 303 311 non-cytoplasmic 312 331 transmembrane 332 354 cytoplasmic 355 378 transmembrane 379 396 non-cytoplasmic 397 418 transmembrane 419 428 cytoplasmic 429 449 transmembrane 450 454 non-cytoplasmic 455 474 transmembrane 475 485 cytoplasmic 486 510 transmembrane 511 522 non-cytoplasmic 523 546 transmembrane 547 572 cytoplasmic 573 596 transmembrane 597 614 non-cytoplasmic 615 633 transmembrane 634 643 cytoplasmic 644 661 transmembrane 662 663 non-cytoplasmic
Input: >H281DRAFT_04922 MNRPTATVAFAAPRAWRLPALLLMLAAWLVYHTLSARLPVAQWPGVVLSGADATLQQLVV RYGWLPRVAIALIAGAALSLAGVVFQQVLRNPLAEPLTLGVSAGAYLALTIAAVVAPALV ADMRFTVALTGAALAMLATMAMTWRKGFAAVSIVLAGMIVNLYCGALSVLLTIVFERSLT SVFIWGGGSLVQNGWAGVVWLLPRVLACGAAAALLVRPLTLFSLDDGSASQLGMSLAWTR PVALAIAVILSAFVASAVGVIGFIGLGGPVLARLMGARRLRDQLLWAPLVGALLLAIADQ AVQSLPGVLGELLPTGAAVALCGGPLLLWMLRRLHVEAPRPASAEHATPRRALRVPVLLL GGLLVAAVVISLCFSVTMQGWQWTDAQHWSDVWFWRVPRLTASLGAGVMVALAGTILQRV TGNPMASPDLLGVSGGAMLGMLVAAVVATEPSTPVLLAGSAAGALVCLLTIVTLGRRSGF APEHVLLAGIAISAFAQAVIMLATASGGAYANLLRPLQYGSTYLIVPATAIAVGVCTVAA VLVAYLGARWLEILPLGANVADALGVGAQRARLLLLAVAAILTAGATVVIGPMSFVGLMA PHLARLLGFPRARSQMLVAALIGGLLMVLSDWLGRNMIFPQQMPAGVIATLLGGPYLMWL LRR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server